My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 125

    1.

    Factors affecting use of insulin pens by patients with type 2 diabetes.

    Rubin RR, Peyrot M.

    Diabetes Care. 2008 Mar;31(3):430-2. Epub 2007 Nov 26.PMID: 18039802 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Physician perception and recommendation of insulin pens for patients with type 2 diabetes mellitus.

    Peyrot M, Rubin RR.

    Curr Med Res Opin. 2008 Aug;24(8):2413-22. Epub 2008 Jul 14.PMID: 18627641 [PubMed - indexed for MEDLINE]Related articles

    3.

    Health care costs and medication adherence associated with initiation of insulin pen therapy in medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.

    Pawaskar MD, Camacho FT, Anderson RT, Cobden D, Joshi AV, Balkrishnan R.

    Clin Ther. 2007;29 Spec No:1294-305.PMID: 18046929 [PubMed - indexed for MEDLINE]Related articles

    4.

    Insulin pen injection devices for management of patients with type 2 diabetes: considerations based on an endocrinologist's practical experience in the United States.

    Thurman JE.

    Endocr Pract. 2007 Oct;13(6):672-8. Review.PMID: 17954427 [PubMed - indexed for MEDLINE]Related articles

    5.

    Patient and physician satisfaction with the Humulin/Humalog Pen, a new 3.0-mL prefilled pen device for insulin delivery.

    Bohannon NJ, Ohannesian JP, Burdan AL, Holcombe JH, Zagar A.

    Clin Ther. 2000 Sep;22(9):1049-67.PMID: 11048904 [PubMed - indexed for MEDLINE]Related articles

    6.

    Patient satisfaction and costs associated with insulin administered by pen device or syringe during hospitalization.

    Davis EM, Christensen CM, Nystrom KK, Foral PA, Destache C.

    Am J Health Syst Pharm. 2008 Jul 15;65(14):1347-57.PMID: 18593681 [PubMed - indexed for MEDLINE]Related articles

    7.

    Acceptability and safety of a new 3.0 ml re-usable insulin pen (HumaPen) in clinical use.

    Martin JM, Llewelyn JA, Ristic S, Bates PC.

    Diabetes Nutr Metab. 1999 Oct;12(5):306-9.PMID: 10741343 [PubMed - indexed for MEDLINE]Related articles

    8.

    Insulin devices: addressing barriers to insulin therapy with the ideal pen.

    Spollett G.

    Diabetes Educ. 2008 Nov-Dec;34(6):957-60, 963, 967.PMID: 19075079 [PubMed - indexed for MEDLINE]Related articles

    9.

    Comparison of usability and patient preference for the new disposable insulin device Solostar versus Flexpen, lilly disposable pen, and a prototype pen: an open-label study.

    Haak T, Edelman S, Walter C, Lecointre B, Spollett G.

    Clin Ther. 2007 Apr;29(4):650-60.PMID: 17617288 [PubMed - indexed for MEDLINE]Related articles

    10.

    A comparison of insulin pen use in the United States and the United Kingdom.

    Da Costa S, Brackenridge B, Hicks D.

    Diabetes Educ. 2002 Jan-Feb;28(1):52-6, 59-60.PMID: 11852744 [PubMed - indexed for MEDLINE]Related articles

    11.

    Initiating insulin therapy in type 2 diabetes: benefits of insulin analogs and insulin pens.

    Brunton S.

    Diabetes Technol Ther. 2008 Aug;10(4):247-56. Review.PMID: 18715198 [PubMed - indexed for MEDLINE]Related articles

    12.

    Patient acceptance and reliability of new Humulin/Humalog 3.0 ml prefilled insulin pen in ten Croatian diabetes centres.

    Sucic M, Galic E, Cabrijan T, Ivandic A, Petrusic A, Wyatt J, Mincheva N, Milicevic Z, Malone J.

    Med Sci Monit. 2002 Mar;8(3):PI21-6.PMID: 11884952 [PubMed - indexed for MEDLINE]Related articles

    13.

    Pen devices to improve patient adherence with insulin therapy in type 2 diabetes.

    Goldstein HH.

    Postgrad Med. 2008 Sep;120(3):172-9. Review.PMID: 18824835 [PubMed - indexed for MEDLINE]Related articles

    14.

    Insulin glargine and glulisine SoloSTAR pens for the treatment of diabetes.

    Garg S, Kelly WC, Garg S.

    Expert Rev Med Devices. 2008 Mar;5(2):113-23. Review.PMID: 18331174 [PubMed - indexed for MEDLINE]Related articles

    15.

    Insulin delivery systems: reducing barriers to insulin therapy and advancing diabetes mellitus treatment.

    Brunton S.

    Am J Med. 2008 Jun;121(6 Suppl):S35-41. Review.PMID: 18514089 [PubMed - indexed for MEDLINE]Related articles

    16.

    The prescription of insulin pen devices versus syringes for older people with diabetes.

    Shaghouli AA, Shah BR.

    Diabetes Technol Ther. 2009 Jul;11(7):439-42.PMID: 19580357 [PubMed - indexed for MEDLINE]Related articles

    17.

    Development of the SoloSTAR insulin pen device: design verification and validation.

    Bode A.

    Expert Opin Drug Deliv. 2009 Jan;6(1):103-12.PMID: 19236211 [PubMed - indexed for MEDLINE]Related articles

    18.

    Assessment of patient-reported outcomes of insulin pen devices versus conventional vial and syringe.

    Molife C, Lee LJ, Shi L, Sawhney M, Lenox SM.

    Diabetes Technol Ther. 2009 Aug;11(8):529-38.PMID: 19698067 [PubMed - in process]Related articles

    19.

    Dosing accuracy of two insulin pre-filled pens.

    Asakura T, Seino H, Kageyama M, Yohkoh N.

    Curr Med Res Opin. 2008 May;24(5):1429-34. Epub 2008 Apr 8.PMID: 18400146 [PubMed - indexed for MEDLINE]Related articles

    20.

    Patient-provider communication and self-care behavior among type 2 diabetes patients.

    Aikens JE, Bingham R, Piette JD.

    Diabetes Educ. 2005 Sep-Oct;31(5):681-90.PMID: 16203852 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity